ScoreComparison
Company
Score
Quality
Valuation
Financial
Technical
Why is Wakamoto Pharmaceutical Co., Ltd. ?
1
Poor Management Efficiency with a low ROE of 0.95%
- The company has been able to generate a Return on Equity (avg) of 0.95% signifying low profitability per unit of shareholders funds
2
Company's ability to service its debt is weak with a poor EBIT to Interest (avg) ratio of -256.03
- Poor long term growth as Net Sales has grown by an annual rate of 0.41% over the last 5 years
- Company's ability to service its debt is weak with a poor EBIT to Interest (avg) ratio of -256.03
- The company has been able to generate a Return on Equity (avg) of 0.95% signifying low profitability per unit of shareholders funds
3
Poor long term growth as Net Sales has grown by an annual rate of 0.41% over the last 5 years
4
Flat results in Jun 26
- NET PROFIT(Q) At JPY 6.71 MM has Fallen at -88.19%
- DEBT-EQUITY RATIO (HY) Highest at -12.95 %
- RAW MATERIAL COST(Y) Grown by 16.95% (YoY)
Real-Time Research ReportHow much should you sell?
- All quantity irrespective of whether you are making profits or losses
(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)
When to re-enter? - We will constantly monitor the company and review our call based on new data
Is Wakamoto Pharmaceutical Co., Ltd. for you?
Low Risk, Low Return
Absolute
Risk Adjusted
Volatility
Wakamoto Pharmaceutical Co., Ltd.
-13.73%
0.11
32.70%
Japan Nikkei 225
60.14%
2.04
29.37%
Quality
Management Risk
Growth
Capital StructureQuality key factors
Factor
Value
Sales Growth (5y)
0.41%
EBIT Growth (5y)
15.97%
EBIT to Interest (avg)
-78.07
Debt to EBITDA (avg)
0
Net Debt to Equity (avg)
-0.25
Sales to Capital Employed (avg)
0.69
Tax Ratio
11.38%
Dividend Payout Ratio
53.46%
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
0.84%
ROE (avg)
0.95%
ValuationValuation Key Factors 
Factor
Value
P/E Ratio
29
Industry P/E
Price to Book Value
0.72
EV to EBIT
99.71
EV to EBITDA
13.90
EV to Capital Employed
0.68
EV to Sales
0.77
PEG Ratio
29.17
Dividend Yield
NA
ROCE (Latest)
0.68%
ROE (Latest)
2.47%
TechnicalsTechnical key factors
Indicator
Weekly
Monthly
MACD
Bearish
Mildly Bearish
RSI
No Signal
No Signal
Bollinger Bands
Mildly Bearish
Bearish
Moving Averages
Bearish (Daily)
KST
Bearish
Mildly Bearish
Dow Theory
No Trend
Mildly Bullish
OBV
No Trend
Mildly Bullish
Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned 
Financial Trend15What is working for the Company
NET PROFIT(HY)
At JPY 18.88 MM has Grown at 175.86%
NET SALES(HY)
At JPY 5,021.92 MM has Grown at 20.98%
ROCE(HY)
Highest at 2.96%
DEBTORS TURNOVER RATIO(HY)
Highest at 3.47 times
-20What is not working for the Company
NET PROFIT(Q)
At JPY 6.71 MM has Fallen at -88.19%
DEBT-EQUITY RATIO
(HY)
Highest at -12.95 %
RAW MATERIAL COST(Y)
Grown by 16.95% (YoY
CASH AND EQV(HY)
Lowest at JPY 3,923.84 MM
INVENTORY TURNOVER RATIO(HY)
Lowest at 1.45 times
INTEREST(Q)
Highest at JPY 1.74 MM
PRE-TAX PROFIT(Q)
At JPY 45.31 MM has Fallen at -29.31%
Here's what is working for Wakamoto Pharmaceutical Co., Ltd.
Net Sales
At JPY 5,021.92 MM has Grown at 20.98%
Year on Year (YoY)MOJO Watch
Near term sales trend is positive
Net Sales (JPY MM)
Debtors Turnover Ratio
Highest at 3.47 times
in the last five Semi-Annual periodsMOJO Watch
Company has been able to sell its Debtors faster
Debtors Turnover Ratio
Depreciation
Highest at JPY 130.03 MM
in the last five periodsMOJO Watch
The expenditure on assets done by the company may have gone into operation
Depreciation (JPY MM)
Here's what is not working for Wakamoto Pharmaceutical Co., Ltd.
Net Profit
At JPY 6.71 MM has Fallen at -88.19%
over average net sales of the previous four periods of JPY 56.8 MMMOJO Watch
Near term Net Profit trend is very negative
Net Profit (JPY MM)
Interest
At JPY 1.74 MM has Grown at 51.13%
period on period (QoQ)MOJO Watch
Rising interest cost signifies increased borrowings
Interest Paid (JPY MM)
Debt-Equity Ratio
Highest at -12.95 % and Grown
In each half year in the last five Semi-Annual periodsMOJO Watch
The company is borrowing more to fund its operations; it's liquidity situation may be stressed
Debt-Equity Ratio
Interest
Highest at JPY 1.74 MM
in the last five periods and Increased by 51.13% (QoQ)MOJO Watch
Rising interest cost signifies increased borrowings
Interest Paid (JPY MM)
Pre-Tax Profit
At JPY 45.31 MM has Fallen at -29.31%
over average net sales of the previous four periods of JPY 64.1 MMMOJO Watch
Near term Pre-Tax Profit trend is negative
Pre-Tax Profit (JPY MM)
Cash and Eqv
Lowest at JPY 3,923.84 MM
in the last six Semi-Annual periodsMOJO Watch
Short Term liquidity is deteriorating
Cash and Cash Equivalents
Inventory Turnover Ratio
Lowest at 1.45 times
in the last five Semi-Annual periodsMOJO Watch
Company's pace of selling inventory has slowed
Inventory Turnover Ratio
Raw Material Cost
Grown by 16.95% (YoY)
MOJO Watch
The company's ability to pass on the cost of raw materials to customers has deteriorated; this may lead to a fall in profit margin
Raw Material Cost as a percentage of Sales
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
